John Evans

About John Evans

Exhibiting both breadth and depth of experience in the pharmaceutical industry, I am a seasoned leader and innovator in sales and marketing across various therapeutic areas, including neuroscience, psychiatry, respiratory, critical care, infectious disease, urology, immunology and biologics. My mission is to bring life-changing medicines to patients in need, while driving business results and maximizing profitability for my company.Currently, I am the New Product Strategy Director for Specialty Therapeutics at GSK, where I have launched a new product for patients with End Stage Renal Disease. Prior to this role, I helped lead the commercialization of biologics for COVID during Emergency Use Authorization as well as lead the development of the US product strategy on multiple mid to late-stage assets in immunology and biologics including shaping key strategies, life cycle plans, and integrated evidence plans to inform GSK Executive Leadership governance decisions. I have a proven track record of marketing innovation, with many firsts in the areas of multichannel and digital marketing at GSK. I have also built and led high-performing teams in sales and marketing, working across the matrix of a large organization and collaborating with various functions and stakeholders. I have extensive customer-facing experience in sales and sales management roles, as well as provider experience in pharmacy, long-term care, hospitals, teaching institutions, surgery centers, and independent providers. I am a registered pharmacist with an MBA and a graduate of the Wharton School Executive Program in Leading Marketing Excellence.

Experience

1. Us New Product Strategy Lead, Renal Therapeutics - Jesduvroq

   GSK

   Jun 2022 — Present · Durham, NC, US

   Marketing Strategy Lead for Jesduvroq®, a new medicinal agent for the treatment of Anemia of Chronic Kidney Disease, launched in February 2023. My role was to develop the launch strategy guide of the brand to consumers and health care providers to achieve forecast revenue goals.

Education

• The University of North Carolina at Chapel Hill

  Batchelor of Science in Pharmacy

  1986 — 1989

• North Carolina State University

  Pre-Pharmacy

  1984 — 1986

• Campbell University

  MBA, Business

  2003 — 2005

• The Wharton School

  Executive Program, Leading Marketing Excellence

  2013 — 2014